|
|
Volumn 24, Issue 1, 1999, Pages 22-29
|
|
SDZ-RAD. Immunosuppressant
a
a
PROUS SCIENCE
(Spain)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
EP 467606;
EP 470804;
EP 475577;
EP 507556;
EP 509795;
EP 512754;
EP 514144;
EP 515140;
EP 516347;
EP 549727;
EVEROLIMUS;
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
US 5023264;
US 5100883;
US 5120727;
US 5138051;
US 5151413;
US 5258389;
WO 9214737;
WO 9221341;
WO 9305046;
WO 9409010;
WO 9425022;
WO 9514023;
WO 9516691;
WO 9606847;
WO 9641807;
ANIMAL CELL;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GRAFT REJECTION;
HEADACHE;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LUNG TRANSPLANTATION;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PNEUMONIA;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 0032995195
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1999.024.01.474036 Document Type: Article |
|
Times cited : (4)
|
|
References (41)
|
